What are the guidelines for managing agitation and trichotillomania?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Agitation and Trichotillomania

Agitation Management

Address reversible causes first through non-pharmacological interventions, then use benzodiazepines or antipsychotics for acute agitation, while trichotillomania requires habit reversal training as first-line therapy with N-acetylcysteine as the primary pharmacological option.

Initial Assessment and Non-Pharmacological Approach

Always begin by identifying and treating reversible causes before considering medications. 1, 2

  • Explore patient concerns and anxieties, ensure effective communication and orientation (explaining where the person is, who they are, and your role) 1
  • Treat specific medical conditions: hypoxia, urinary retention, constipation, pain, infections, dehydration, and electrolyte disturbances 2
  • Provide adequate lighting and explain to caregivers how they can help 1, 2
  • Implement verbal de-escalation: respect personal space, use calm demeanor, designate one staff member to interact, use simple language, and set clear limits 2, 3

Pharmacological Management for Acute Agitation

For patients able to swallow:

  • Lorazepam 0.5-1 mg orally four times daily as needed (maximum 4 mg/24 hours) is the benzodiazepine of choice 1
  • Reduce to 0.25-0.5 mg in elderly or debilitated patients (maximum 2 mg/24 hours) 1, 2
  • Oral tablets can be used sublingually 1

For delirium with agitation (able to swallow):

  • Haloperidol 0.5-1 mg orally at night and every 2 hours when required 1, 2, 4
  • Increase in 0.5-1 mg increments as needed (maximum 10 mg daily, or 5 mg daily in elderly) 1
  • Consider higher starting dose (1.5-3 mg) if severely distressed or causing immediate danger 1
  • Add benzodiazepine if agitation persists despite adequate haloperidol 1, 4

For patients unable to swallow:

  • Midazolam 2.5-5 mg subcutaneously every 2-4 hours as needed 1
  • If needed frequently (>twice daily), consider subcutaneous infusion starting with midazolam 10 mg over 24 hours 1
  • Reduce to 5 mg over 24 hours if eGFR <30 mL/min 1

Special Populations

Elderly patients on comfort measures:

  • Haloperidol remains first-line at 0.5-1 mg orally, maximum 5 mg daily 4
  • Alternative antipsychotics: risperidone 0.5-1 mg twice daily, olanzapine 2.5-15 mg daily, or quetiapine 50-100 mg twice daily 4
  • Lorazepam 0.25-0.5 mg in elderly (maximum 2 mg/24 hours) 4

Hospitalized older adults:

  • Multicomponent nonpharmacologic interventions are first-line; reserve antipsychotics ONLY for severe distress with hallucinations/delusions or imminent harm 2
  • The ABCDEF bundle (Assessment of pain, Both spontaneous awakening/breathing trials, Choice of sedation, Delirium monitoring, Early mobility, Family engagement) reduces mortality 2
  • Discontinue antipsychotics immediately once agitation resolves 2

Critical Care Setting

  • IV opioids are first-line for non-neuropathic pain in critically ill patients 1
  • Pain should be routinely monitored using Behavioral Pain Scale (BPS) or Critical-Care Pain Observation Tool (CPOT) 1
  • Preemptive analgesia and/or nonpharmacologic interventions before painful procedures 1

Emergency Department Management

For undifferentiated acute agitation:

  • Use benzodiazepine (lorazepam or midazolam) OR conventional antipsychotic (droperidol or haloperidol) as monotherapy 1
  • If rapid sedation required, consider droperidol instead of haloperidol 1
  • Combination of parenteral benzodiazepine and haloperidol may produce more rapid sedation than monotherapy 1

For cooperative agitated patients:

  • Combination of oral lorazepam and oral risperidone is effective 1

Common Pitfalls to Avoid

  • Never fail to identify and treat underlying medical causes before medicating 2
  • Avoid high doses in elderly without appropriate dose adjustments 2
  • Do not neglect non-pharmacological approaches before initiating medications 2
  • Avoid physical restraints, which worsen delirium and outcomes 2
  • Do not continue antipsychotics after agitation resolves 2

Trichotillomania Management

First-Line Behavioral Treatment

Habit reversal training (HRT) and stimulus control are first-line treatments for all severity levels, particularly when pulling is performed with lowered awareness. 5

  • HRT is most effective when pulling occurs with lowered awareness/intention 5
  • Stimulus control techniques should be implemented alongside HRT 5

Augmentation Strategies for Emotional Triggers

When negative emotions trigger pulling:

  • Acceptance and commitment therapy (ACT) can augment HRT/stimulus control 5
  • Dialectical behavior therapy (DBT) is effective for emotion-driven pulling 5

Pharmacological Management

N-acetylcysteine (NAC) should be considered for all severity levels given its moderate efficacy and low side effect profile. 5

For treatment-resistant cases or significant comorbidities:

  • Selective serotonin reuptake inhibitors (SSRIs) should be considered after behavioral/NAC treatment failure 5
  • No FDA-approved pharmacologic treatments currently exist for trichotillomania 5

Pediatric Considerations

  • Mean age of onset is 11.3 years (range 8-13 years) 6
  • Triggers include psychosocial stressors: separation from attachment figures, hospitalization, birth of sibling, sibling rivalry, moving, or school performance problems 6
  • Cognitive behavioral therapy is first-line in children 6
  • Mild topical steroids (hydrocortisone butyrate 0.1% solution) and methionine capsules may be used adjunctively 6
  • Psychopharmacologic therapy should be reserved for cases not responding to behavioral interventions 6

Diagnostic Confirmation

  • Trichoscopy and skin biopsy confirm diagnosis 6
  • Histology shows increased catagen/telogen hairs, pigment casts, empty anagen follicles, and perifollicular hemorrhage 6
  • Screen for trichophagia (hair ingestion), present in 5-30% of adults but less common in children 6

Monitoring for Complications

  • Watch for secondary bacterial infections with regional lymphadenopathy 6
  • Screen for trichobezoar if trichophagia present: pallor, nausea, vomiting, anorexia, weight loss 6
  • Consider radiologic examination and gastroscopy if trichobezoar suspected 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Agitated Aggressive Elderly Inpatients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Agitation in Elderly Patients on Comfort Measures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.

Acta dermatovenerologica Croatica : ADC, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.